LSE : 0J5Q.L

Hologic, Inc.

$75.615 USD

$0.07 (0.1%)

Volume
31.96K
Average Volume
3.14K
Market Capitalization
$16.88B
P/E Ratio
31.28
Dividend Yield
0.00%
Price Target
Year High
$86.55
Year Low
$64.69
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$4.04
Company Overview

LSE

Paul Malenchini

Medical - Equipment & Services

Healthcare

0J5Q.L

7063

US

USD

https://www.hologic.com

508 263 2900

N/A

N/A

Liquidity Metrics

0.48

4.04

3.32

2.28

0.00

Sales & Valuation

$4.1B

4.11

3.25

16.98

4.45

Profitability

$2.49

$565.7M

13.18%

16.08%

11.01%

5.92%

P/E Metrics

31.28

-1.33

-1.33

Analyst Price Target & Rating

N/A

0/5

40 Analysts

%

Financial Health Scores

4.30

7/9

$2.89B

$9.18B

$3.94B

$981.1M

Key Metrics (TTM)

No key metrics data available.

Company Executives
Name Title
Anne Liddy General Counsel
Scott Christensen Senior Vice President of Global Supply Chain & Regulatory Affairs
Diana De Walt SPHR Senior Vice President of Global Human Resources
Karleen Oberton Chief Financial Officer
Monica Aguirre Berthelot Vice President & Chief of Staff
Benjamin Cohn Vice President & Corporate Controller
Essex Mitchell Chief Operating Officer
Jan Verstreken Group President of International
Michael J. Watts Corporate Vice President of Investor Relations
Paul Malenchini Chief Information Officer
Stephen MacMillan Chairman, Chief Executive Officer & President
Jennifer Schneiders President of Diagnostic Solutions
Mark Horvath President of Breast & Skeletal Health Solutions
Mark Irving Vice President & Corporate Secretary
Brandon Schnittker President of GYN Surgical Solutions
Poll Results

No votes yet today — be the first to share your view!

About Hologic, Inc. (LSE:0J5Q.L) Stock

Hologic, Inc., founded in 1985 and headquartered in Marlborough, Massachusetts, is a global medical technology company. It focuses on developing, manufacturing, and marketing diagnostics, medical imaging, and surgical solutions, with a primary emphasis on advancing women's health through early detection and therapeutic interventions. Its operations are structured into four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health, catering to markets across the United States, Europe, Asia-Pacific, and other global territories. In its Diagnostics division, Hologic provides a range of products, including Aptima molecular assays for identifying infectious microorganisms, viral load tests for conditions such as HIV, Hepatitis C, and Hepatitis B, alongside Aptima and Panther Fusio ... n SARS-CoV-2 assays. Other offerings in this segment include the ThinPrep System for cytology applications, the Rapid Fetal Fibronectin Test to evaluate preterm birth risk, and various diagnostic tests for Group B Streptococcus. The Breast Health segment delivers extensive solutions for breast imaging and analytics. These encompass 2D and 3D digital mammography systems, advanced reading workstations, minimally invasive biopsy guidance systems and devices, breast biopsy markers and localization tools, specimen radiology, ultrasound, connectivity solutions, and products for breast-conserving surgery. Within its GYN Surgical offerings, the company supplies the NovaSure Endometrial Ablation System for managing abnormal uterine bleeding, the MyoSure Hysteroscopic Tissue Removal System for excising fibroids, polyps, and other uterine pathologies, and the Fluent Fluid Management System to facilitate liquid distention during hysteroscopic diagnostic and operative procedures. Its Skeletal Health division offers the Horizon DXA, a dual-energy X-ray system, and the Fluoroscan Insight FD mini C-arm, used for minimally invasive orthopedic surgical interventions. The company markets its products through both its direct sales and service personnel, as well as independent distributors and sales representatives.

Frequently Asked Questions

What is the current Hologic, Inc. (0J5Q.L) stock price?

Hologic, Inc.(LSE:0J5Q.L) stock price is $75.615 in the last trading session. During the trading session, 0J5Q.L stock reached the peak price of $86.545 while $64.6872 was the lowest point it dropped to. The percentage change in 0J5Q.L stock occurred in the recent session was 0.1% while the dollar amount for the price change in 0J5Q.L stock was $0.07.

0J5Q.L's industry and sector of operation?

The LSE listed 0J5Q.L is part of Medical - Equipment & Services industry that operates in the broader Healthcare sector.

Who are the executives of 0J5Q.L?

Anne Liddy | General Counsel
Scott Christensen | Senior Vice President of Global Supply Chain & Regulatory Affairs
Diana De Walt SPHR | Senior Vice President of Global Human Resources
Karleen Oberton | Chief Financial Officer
Monica Aguirre Berthelot | Vice President & Chief of Staff

How many employees does 0J5Q.L have?

Number of 0J5Q.L employees currently stands at 7063. 0J5Q.L operates from 250 Campus Drive, Marlborough, MA 01752, US.

Link for 0J5Q.L official website?

Official Website of 0J5Q.L is: https://www.hologic.com

How do I contact 0J5Q.L?

0J5Q.L could be contacted at phone #508 263 2900 and can also be accessed through its website. 0J5Q.L operates from 250 Campus Drive, Marlborough, MA 01752, US.

How many shares of 0J5Q.L are traded daily?

The average number of 0J5Q.L shares traded daily for last 3 months was 3.14K.

What is the market cap of 0J5Q.L currently?

The market value of 0J5Q.L currently stands at $16.88B with its latest stock price at $75.615